See inside every stock. Pro
S&P 5007,624▼ 0.52%Nasdaq25,955▼ 0.21%Dow Jones52,215▼ 1.23%Nasdaq 10028,958▼ 0.00%VIX19.45▲ 2.21%US Dollar101.75▲ 0.14%Gold spot4,012▼ 0.30%WTI103.27▲ 3.82%
← 0ADJ page
XStocksXray
Market X-Ray report · 23 October 2026

Bunge Global SA (0ADJ)

London Exchange · UK · prices in USD · close of 23 Oct 2026

Key indicators

Last closeUSD 103.54
52-week range87.98 – 134.85
Return, 1 month / 3 months−7.0% / −15.6%
Return, 1 year / 3 years– / –
TrendBelow its 200-day average
RSI (14)40
Volatility (1 year)32.9%
Worst drawdown (1 year)-24.6%
Average daily value traded0.28M USD
Dividend yield–

Market X-Ray price-based

37/ 100 · Medium confidence · ahead of 27% of stocks on this exchange
Trend33
Momentum20
Stability (higher is calmer)58
Liquidity40
Income–

Five-year price chart navy: price · brown: 200-day average

85.9998.791121241372025-122026-022026-052026-082026-10

About the company

Bunge Global is an agribusiness and food company that buys, stores, transports and processes agricultural commodities. It crushes oilseeds such as soybeans and rapeseed into protein meal for animal feed and vegetable oils for food and industrial use, and it trades and distributes grains. Its food ingredients business supplies customers such as food processors, bakeries and feed producers. The company operates internationally, with its main headquarters in the United States.

On this site Bunge Global SA appears as a stock on the London Exchange (UK), code 0ADJ, with prices in US dollars (USD). Dividend data for this stock is not available yet. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Bunge Global SA (0ADJ) trades on the London Exchange in UK. It last closed at USD 103.54 on 23 October 2026.

Its price-based Market X-Ray is 37 out of 100 (a weak price profile), ranking 2,763 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Bunge Global SA (0ADJ)

The five lenses in numbers each metric is ranked against the other stocks on London Exchange

Lens and metricValueScoreReading
Trend33 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-11.6%
From 52-week high-23.0%
Momentum20 · WeakLagging most stocks on this exchange.
3-month return-15.6%
6-month return-18.0%
12-month return, skipping the last month–
Stability (higher is calmer)58 · FairTypical risk for this exchange.
Volatility, 1 year (lower is calmer)32.9%
Worst drawdown, 1 year (smaller is calmer)-24.6%
Liquidity40 · WeakThinly traded: prices can jump and exits can be hard.
Average daily value traded0.28M USD
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

No lens stands out as a clear strength against its exchange.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Momentum: Lagging most stocks on this exchange.
  • Liquidity: Thinly traded: prices can jump and exits can be hard.

Returns

1 week−2.4%
1 month−7.0%
3 months−15.6%
6 months−18.0%
1 year–
3 years–
5 years–

Signals

50-day / 200-day average112.34 / 117.09
Golden / death cross (60 days)Death, 21 days ago
New 52-week highNo
Bullish RSI divergenceYes
Average daily range (ATR)4.05

Technical summary

DailyStrongly bearish1 bullish · 3 neutral · 11 bearish
WeeklyStrongly bearish0 bullish · 1 neutral · 6 bearish
MonthlyStrongly bearish0 bullish · 0 neutral · 1 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 24 Oct 2026